BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37530800)

  • 1. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
    Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment.
    Ye Y; Zeng S; Hu X
    Apoptosis; 2024 Jun; 29(5-6):693-708. PubMed ID: 38296888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.
    Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G
    Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669
    [No Abstract]   [Full Text] [Related]  

  • 6. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
    Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
    BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
    Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
    J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1.
    Yang L; Liu J; Li S; Liu X; Zheng F; Xu S; Fu B; Xiong J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9787-9804. PubMed ID: 37247081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
    Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
    Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease.
    Yu X; Guo Z; Fang Z; Yang K; Liu C; Dong Z; Liu C
    Front Genet; 2023; 14():1251999. PubMed ID: 37745847
    [No Abstract]   [Full Text] [Related]  

  • 11. Identifying molecular subtypes and tumor microenvironment infiltration signatures in kidney renal clear cell carcinoma based on stemness-associated disulfidptosis genes by integrating machine learning, single-cell analyses and experimental validation.
    Liu H; Liang X; Tang G; Wang X; Wang Z; Tong L; Mao Q; Ma J; Wu J
    Heliyon; 2024 Feb; 10(4):e26094. PubMed ID: 38390172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer's disease molecular subtypes.
    Zhu Y; Kong L; Han T; Yan Q; Liu J
    Immun Inflamm Dis; 2023 Oct; 11(10):e1037. PubMed ID: 37904698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
    Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
    Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature.
    Tang C; Fan Y; Zhu S
    BMC Urol; 2024 Mar; 24(1):69. PubMed ID: 38532369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma.
    Deng W; Xie Z; Chen L; Li W; Li M
    Aging (Albany NY); 2024 Jan; 16(2):1249-1275. PubMed ID: 38271056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma.
    Yi B; Wei X; Liu D; Jing L; Xu S; Zhang M; Liang Z; Liu R; Zhang Z
    Aging (Albany NY); 2024 Feb; 16(4):3647-3673. PubMed ID: 38358909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and experimental verification of a prognosis model for disulfidptosis-associated genes in HNSCC.
    Li Y; Tao L; Xin J; Dai Y; Chen X; Zou J; Wang R; Wang B; Liu Z
    Medicine (Baltimore); 2024 Mar; 103(12):e37308. PubMed ID: 38518012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.
    Cong Y; Cai G; Ding C; Zhang H; Chen J; Luo S; Liu J
    Front Genet; 2024; 15():1378907. PubMed ID: 38694875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
    Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
    J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.